Are there any drawbacks for continuation of empirical meropenem treatment?

Future Microbiol. 2025 Dec;20(18):1301-1304. doi: 10.1080/17460913.2025.2603852. Epub 2025 Dec 16.

Authors

Sahjid Mukhida¹, Nikunja Kumar Das², Sriram Kannuri³, Sameena Khan¹, Deepali Desai¹

Affiliations

¹ Department of Microbiology, Dr. D. Y. Patil Medical College, Hospital and Research Centre, Dr. D. Y. Patil Vidyapeeth, Pimpri, Pune, India.
² Department of Microbiology, DRIEMS Institute of Health Sciences and Hospital, Kotasahi, Tangi, India.
³ Department of Microbiology, All India Institute of Medical Science, Mangalagiri, Guntur, India.

PMID: 41400307
PMCID: PMC12758231 (available on 2026-12-16)
DOI: 10.1080/17460913.2025.2603852

No abstract available

Keywords: Antimicrobial resistance; antimicrobial stewardship; carbapenem; empirical; meropenem.

Publication types

Editorial